The comparison of ERBB2 expression on CTC and tumor tissue resulted in an overall concordance of 74% and 89% when comparing CTC with the primary tumor and 69% when compared to metastases, respectively [29, 45]. This evidence concerns the gene ERBB2 and neoplasm.